Page last updated: 2024-10-24

chlorambucil and Delayed Effects, Prenatal Exposure

chlorambucil has been researched along with Delayed Effects, Prenatal Exposure in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, R1
Ozkalemkas, F1
Kimya, Y1
Koksal, N1
Ozkocaman, V1
Yorulmaz, H1
Eroglu, A1
Ozcelik, T1
Tunali, A1
Kavlock, RJ1
Rehnberg, BF1
Rogers, EH1

Other Studies

2 other studies available for chlorambucil and Delayed Effects, Prenatal Exposure

ArticleYear
Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil.
    Leukemia research, 2009, Volume: 33, Issue:4

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Agents, Alkylating; Chlorambucil; Female; Fetus;

2009
Critical prenatal periods for chlorambucil-induced functional alterations of the rat kidney.
    Toxicology, 1987, Volume: 43, Issue:1

    Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Chlorambucil; Female; Gestational Age; Kidney; Li

1987